Jefferies Reiterates $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX)

Jefferies Reiterates $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX)

Equity Research Firm Jefferies Reiterated its $3.50 price target on AcelRx Pharmaceuticals Inc(NASDAQ:ACRX) and Issued a Research Report titled ”ACRX: HOLD: Key Takeaways from R&D Day” on October 2. Equity Analysts Biren Amin, Hugo Ong, Ph.D., and Shaunak Deepak stated ”At its R&D Day, ACRX reviewed its pipeline portfolio which included a focus on ARX-04 which could be the next meaningful revenue opportunity. Based on clinical data and market research, […]

Read More ˃
BTIG Equity Research Reiterates $12 Price Target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)

BTIG Equity Research Reiterates $12 Price Target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX)

Equity Analyst Hartaj Singh of BTIG Equity Research reiterated his $12 price target on Progenics Pharmaceuticals, Inc.(NASDAQ:PGNX) October 3 in a research report titled ”Pipeline Focus Increasing.” According to Hartaj Singh ”PGNX is more than a play on Relistor royalties, with three mid/late stage assets that are positioning the company closer to creating a valuation rerating. Company management continues to demonstrate that they are building franchises that meet important unmet […]

Read More ˃
Sadif Issues Summary Due Diligence Report on Canadian Solar Inc.(NASDAQ:CSIQ)

Sadif Issues Summary Due Diligence Report on Canadian Solar Inc.(NASDAQ:CSIQ)

On September 29 Sadif Newsletter  & Investment Management Portal Issued a Summary Due Diligence Report on Canadian Solar Inc.(NASDAQ:CSIQ) titled ”Is There Long-Term Value in Canadian Solar Inc.?” The report states that ”Canadian Solar Inc. is a high quality company with a neutral outlook.Canadian Solar Inc. has strong business growth and is run by efficient management. The trend in Canadian Solar Inc. fair value exchange rate against its closest rated-competitor, […]

Read More ˃
Sadif Issues Summary Due Diligence Report on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS)

Sadif Issues Summary Due Diligence Report on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS)

On September 29 Sadif Newsletter  & Investment Management Portal Issued a Summary Due Diligence Report on AEterna Zentaris Inc. (USA)(NASDAQ:AEZS) titled ”Will AEterna Zentaris Inc. Bounce Back?” The report states that ”AEterna Zentaris Inc. is an average quality company with a positive outlook. AEterna Zentaris Inc. has weak business growth and is run by mediocre management. The trend in AEterna Zentaris Inc. fair value exchange rate against its closest rated-competitor, […]

Read More ˃